Beam Therapeutics Inc.
BEAM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$376,742 | -$132,527 | -$289,088 | -$370,638 |
| Dep. & Amort. | $21,925 | $20,012 | $14,147 | $7,451 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $120,662 | $98,647 | $84,321 | $43,570 |
| Change in WC | -$110,223 | -$116,455 | $251,628 | $111,254 |
| Other Non-Cash | -$2,868 | -$18,872 | -$38,481 | $142,095 |
| Operating Cash Flow | -$347,246 | -$149,195 | $22,527 | -$66,268 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$8,946 | -$33,732 | -$48,951 | -$46,811 |
| Net Acquisitions | $0 | $0 | $412,385 | $620 |
| Inv. Purchases | -$486,439 | -$984,338 | -$1,616,999 | -$777,223 |
| Inv. Sales/Matur. | $680,392 | $1,089,910 | $1,204,614 | $529,270 |
| Other Inv. Act. | $0 | $0 | -$412,385 | $0 |
| Investing Cash Flow | $185,007 | $71,840 | -$461,336 | -$294,144 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$485 | -$2,252 | -$2,287 | -$2,118 |
| Stock Issued | $8,221 | $270,168 | $108,258 | $757,449 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $8,532 | $5,619 | $810 |
| Financing Cash Flow | $7,736 | $276,448 | $111,590 | $756,141 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$154,503 | $199,093 | -$327,219 | $395,729 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $444,614 | $245,521 | $572,740 | $177,011 |
| End Cash | $290,111 | $444,614 | $245,521 | $572,740 |
| Free Cash Flow | -$356,192 | -$182,927 | -$26,424 | -$113,079 |